All Articles

Cabot Corporation's sixth EcoVadis Platinum rating is more than an award; it highlights a crucial evolution in corporate accountability, ethics, and trust.

MorningBlues' new SonicGlass A1 isn't just a speaker; it's a transparent art piece that generates AI music videos. Is this the future of home audio?

Quoin Pharma is making a bold bet, building a full commercial operation in Japan for its rare disease drug years before a potential launch. Is this the new model?

Spurred by national policy and landmark listings, Japan's innovators are looking to U.S. capital markets for global growth. A new summit maps the path.

A landmark deal for Eos's zinc battery tech, backed by Cerberus capital, aims to solve Texas's grid woes and prove a new model for energy storage finance.

New data reveals a 'Women CEO Effect'—companies led by women don't just break ceilings, they build entirely new pipelines for female leadership.

SRx Health Solutions rebrands as SRX Global after acquiring a crypto AI firm. But with a history of pivots and a 35% stock drop, is this a brilliant rebirth or a desperate gamble?

GCL's deal for 'A Whisper of Fall: Jinyiwei' isn't just another game. It's a strategic move capitalizing on the global hunger for authentic Asian IP.

Nuwellis bets on educating hundreds of physicians on its Aquadex system, a high-stakes strategy to combat fluid overload and secure its place in medicine.

The gas shipping giant just secured $206 million for new vessels, but the real story isn't the money—it's the sophisticated financial tool they used.

With a $19.4M Series A from heavyweights like BHP, Cuprum Metals is scaling a technology that could finally crack chalcopyrite, the holy grail of copper ore.

Aether Holdings launches Alphid, an AI platform connecting to brokerage accounts. Is this the key to leveling the playing field for retail investors, or a new risk?

A public company is offering a volatile mix of OpenAI, Worldcoin, and MrBeast. We deconstruct the high-risk, high-reward strategy behind its unique treasury.

Silo Pharma has navigated a critical headwind, regaining Nasdaq compliance. This move provides vital stability, allowing the firm to focus on its true test.

The appointment of Bethany Sensenig, a veteran of PE-backed turnarounds, signals CenExel is preparing for a major push to dominate the clinical research market.

A $10,000 award to a future cyber defender is more than a press release. It's a look at how industry giants are tackling the global talent crisis.

Utah's Co-Diagnostics is transferring its AI-powered diagnostic platform to a Saudi JV. It's a bold move to crack a booming market and a critical test of its strategy.

Scienture Holdings' Arbli™ just gained 12.5M covered lives. It's not about the $219M market, but the overlooked patients who can't swallow pills.

Intelinair's new AGMRI AI Agent promises instant answers to complex farm questions. Is this the tool that finally tames agricultural data for good?

Amid a spiraling insurance crisis, a new company called Stand is betting it can fix Florida's broken market by modeling risk down to the nail and rewarding resilience.